1rs9

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1rs9" size="450" color="white" frame="true" align="right" spinBox="true" caption="1rs9, resolution 2.22&Aring;" /> '''Bovine endothelial N...)
Line 1: Line 1:
-
[[Image:1rs9.gif|left|200px]]<br /><applet load="1rs9" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1rs9.gif|left|200px]]<br /><applet load="1rs9" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1rs9, resolution 2.22&Aring;" />
caption="1rs9, resolution 2.22&Aring;" />
'''Bovine endothelial NOS heme domain with D-phenylalanine-D-nitroarginine amide bound'''<br />
'''Bovine endothelial NOS heme domain with D-phenylalanine-D-nitroarginine amide bound'''<br />
==Overview==
==Overview==
-
In a continuing effort to unravel the structural basis for, isoform-selective inhibition of nitric oxide synthase (NOS) by various, inhibitors, we have determined the crystal structures of the nNOS and eNOS, heme domain bound with two D-nitroarginine-containing dipeptide, inhibitors, D-Lys-D-Arg(NO)2-NH(2) and D-Phe-D-Arg(NO)2-NH(2). These two, dipeptide inhibitors exhibit similar binding modes in the two constitutive, NOS isozymes, which is consistent with the similar binding affinities for, the two isoforms as determined by K(i) measurements. The, D-nitroarginine-containing dipeptide inhibitors are not distinguished by, the amino acid difference between nNOS and eNOS (Asp 597 and Asn 368, respectively) which is key in controlling isoform selection for nNOS over, eNOS observed for the L-nitroarginine-containing dipeptide inhibitors, reported previously [Flinspach, M., et al. (2004) Nat. Struct. Mol. Biol., 11, 54-59]. The lack of a free alpha-amino group on the D-nitroarginine, moiety makes the dipeptide inhibitor steer away from the amino acid, binding pocket near the active site. This allows the inhibitor to extend, into the solvent-accessible channel farther away from the active site, which enables the inhibitors to explore new isoform-specific, enzyme-inhibitor interactions. This might be the structural basis for why, these D-nitroarginine-containing inhibitors are selective for nNOS (or, eNOS) over iNOS.
+
In a continuing effort to unravel the structural basis for isoform-selective inhibition of nitric oxide synthase (NOS) by various inhibitors, we have determined the crystal structures of the nNOS and eNOS heme domain bound with two D-nitroarginine-containing dipeptide inhibitors, D-Lys-D-Arg(NO)2-NH(2) and D-Phe-D-Arg(NO)2-NH(2). These two dipeptide inhibitors exhibit similar binding modes in the two constitutive NOS isozymes, which is consistent with the similar binding affinities for the two isoforms as determined by K(i) measurements. The D-nitroarginine-containing dipeptide inhibitors are not distinguished by the amino acid difference between nNOS and eNOS (Asp 597 and Asn 368, respectively) which is key in controlling isoform selection for nNOS over eNOS observed for the L-nitroarginine-containing dipeptide inhibitors reported previously [Flinspach, M., et al. (2004) Nat. Struct. Mol. Biol. 11, 54-59]. The lack of a free alpha-amino group on the D-nitroarginine moiety makes the dipeptide inhibitor steer away from the amino acid binding pocket near the active site. This allows the inhibitor to extend into the solvent-accessible channel farther away from the active site, which enables the inhibitors to explore new isoform-specific enzyme-inhibitor interactions. This might be the structural basis for why these D-nitroarginine-containing inhibitors are selective for nNOS (or eNOS) over iNOS.
==About this Structure==
==About this Structure==
-
1RS9 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with CAC, ACT, ZN, HEM, H4B, D7P and GOL as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Nitric-oxide_synthase Nitric-oxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1RS9 OCA].
+
1RS9 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with <scene name='pdbligand=CAC:'>CAC</scene>, <scene name='pdbligand=ACT:'>ACT</scene>, <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=HEM:'>HEM</scene>, <scene name='pdbligand=H4B:'>H4B</scene>, <scene name='pdbligand=D7P:'>D7P</scene> and <scene name='pdbligand=GOL:'>GOL</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Nitric-oxide_synthase Nitric-oxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1RS9 OCA].
==Reference==
==Reference==
Line 18: Line 18:
[[Category: Jamal, J.]]
[[Category: Jamal, J.]]
[[Category: Li, H.]]
[[Category: Li, H.]]
-
[[Category: Poulos, T.L.]]
+
[[Category: Poulos, T L.]]
-
[[Category: Silverman, R.B.]]
+
[[Category: Silverman, R B.]]
[[Category: Yang, W.]]
[[Category: Yang, W.]]
[[Category: ACT]]
[[Category: ACT]]
Line 32: Line 32:
[[Category: oxidoreductase]]
[[Category: oxidoreductase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 01:50:13 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:53:59 2008''

Revision as of 12:54, 21 February 2008


1rs9, resolution 2.22Å

Drag the structure with the mouse to rotate

Bovine endothelial NOS heme domain with D-phenylalanine-D-nitroarginine amide bound

Overview

In a continuing effort to unravel the structural basis for isoform-selective inhibition of nitric oxide synthase (NOS) by various inhibitors, we have determined the crystal structures of the nNOS and eNOS heme domain bound with two D-nitroarginine-containing dipeptide inhibitors, D-Lys-D-Arg(NO)2-NH(2) and D-Phe-D-Arg(NO)2-NH(2). These two dipeptide inhibitors exhibit similar binding modes in the two constitutive NOS isozymes, which is consistent with the similar binding affinities for the two isoforms as determined by K(i) measurements. The D-nitroarginine-containing dipeptide inhibitors are not distinguished by the amino acid difference between nNOS and eNOS (Asp 597 and Asn 368, respectively) which is key in controlling isoform selection for nNOS over eNOS observed for the L-nitroarginine-containing dipeptide inhibitors reported previously [Flinspach, M., et al. (2004) Nat. Struct. Mol. Biol. 11, 54-59]. The lack of a free alpha-amino group on the D-nitroarginine moiety makes the dipeptide inhibitor steer away from the amino acid binding pocket near the active site. This allows the inhibitor to extend into the solvent-accessible channel farther away from the active site, which enables the inhibitors to explore new isoform-specific enzyme-inhibitor interactions. This might be the structural basis for why these D-nitroarginine-containing inhibitors are selective for nNOS (or eNOS) over iNOS.

About this Structure

1RS9 is a Single protein structure of sequence from Bos taurus with , , , , , and as ligands. Active as Nitric-oxide synthase, with EC number 1.14.13.39 Full crystallographic information is available from OCA.

Reference

Structures of the neuronal and endothelial nitric oxide synthase heme domain with D-nitroarginine-containing dipeptide inhibitors bound., Flinspach M, Li H, Jamal J, Yang W, Huang H, Silverman RB, Poulos TL, Biochemistry. 2004 May 11;43(18):5181-7. PMID:15122883

Page seeded by OCA on Thu Feb 21 14:53:59 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools